Matchpoint Therapeutics Inc. — Form D
Matchpoint Therapeutics Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-17. The offering totals $70.0M, of which $42.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-10-17
- Form: D
- Accession: 0001950915-22-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $70.0M
- Amount sold: $42.0M
- Remaining: $28.0M
- Investors: 15
- Date of first sale: 2022-10-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-462017
Issuer
- Name: Matchpoint Therapeutics Inc.
- CIK: 0001950915
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: ONE KENDALL SQUARE, CAMBRIDGE, MA, 02139
- Phone: 617-620-6280
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Daniel Becker | Director | Cambridge, MA |
| Bruce Booth | Director | Cambridge, MA |
| Jason Hafler | Director | South San Francisco, CA |
| Andre Turenne | Director | Mountain View, CA |
| Andre Turenne | Executive Officer | Mountain View, CA |
More